---
figid: PMC5639976__10.1177_2040620717721459-fig1
figlink: /pmc/articles/PMC5639976/figure/fig1-2040620717721459/
number: Figure 1
caption: Agents with potential synergistic activity with midostaurin in AML. Agents
  with additive and/or synergistic potential when combined with midostaurin are illustrated
  alongside their respective target pathways. (a) STAT5a, Ras/MEK, and PI3K/Akt/mTOR
  are established FLT3-dependent signaling pathways, and may be inhibited further
  by the agents listed. (b) CDDO-Me targets multiple pathways, including NFκB which
  is not an established FLT3-dependent signaling pathway. (c) Activation of the JAK/STAT
  pathway by cytokines released from bone marrow stromal cells is hypothesized to
  overcome FLT3 inhibition within the bone marrow environment. Individual agents are
  discussed in detail in the section Agents exhibiting additive or synergistic effects
  with midostaurin in FLT3-mut AML.FLT3-mut (FLT3-ITD and FLT3-TKD) are constitutively
  active; FLT3-WT requires FL stimulation.FL, FLT3 ligand; BMS, bone marrow stromal.
pmcid: PMC5639976
papertitle: 'Midostaurin: a novel therapeutic agent for patients with FLT3-mutated
  acute myeloid leukemia and systemic mastocytosis.'
reftext: Molly M. Gallogly, et al. Ther Adv Hematol. 2017 Sep;8(9):245-261.
pmc_ranked_result_index: '92514'
pathway_score: 0.8536949
filename: 10.1177_2040620717721459-fig1.jpg
figtitle: Agents with potential synergistic activity with midostaurin in AML
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5639976__10.1177_2040620717721459-fig1.html
  '@type': Dataset
  description: Agents with potential synergistic activity with midostaurin in AML.
    Agents with additive and/or synergistic potential when combined with midostaurin
    are illustrated alongside their respective target pathways. (a) STAT5a, Ras/MEK,
    and PI3K/Akt/mTOR are established FLT3-dependent signaling pathways, and may be
    inhibited further by the agents listed. (b) CDDO-Me targets multiple pathways,
    including NFκB which is not an established FLT3-dependent signaling pathway. (c)
    Activation of the JAK/STAT pathway by cytokines released from bone marrow stromal
    cells is hypothesized to overcome FLT3 inhibition within the bone marrow environment.
    Individual agents are discussed in detail in the section Agents exhibiting additive
    or synergistic effects with midostaurin in FLT3-mut AML.FLT3-mut (FLT3-ITD and
    FLT3-TKD) are constitutively active; FLT3-WT requires FL stimulation.FL, FLT3
    ligand; BMS, bone marrow stromal.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - JAK1
  - JAK2
  - HRAS
  - MAP2K2
  - MAP2K1
  - KRAS
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - NRAS
  - JAK3
  - TYK2
  - STAT6
  - REL
  - FLT3
  - STAT1
  - RELA
  - RELB
  - NFKB1
  - AKT2
  - AKT3
  - AKT1
  - STAT5B
  - STAT4
  - STAT5A
  - NFKB2
  - PIK3R4
  - PIK3CA
  - PIK3R6
  - STAT2
  - PIK3R5
  - MTOR
  - midostaurin H
  - U0126
  - "CDDO-Me \x1F"
  - Pimozide
  - rapamycin
  - Cancer
genes:
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: FLT3
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: midostaurin H
  source: MESH
  identifier: C059539
- word: U0126
  source: MESH
  identifier: C113580
- word: "CDDO-Me \x1F"
  source: MESH
  identifier: C445068
- word: Pimozide
  source: MESH
  identifier: D010868
- word: rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
